 Clinical characteristics nonfatal myocardial infarction individuals prophylactic low-dose aspirin therapy BACKGROUND influence prophylactic low-dose aspirin clinical characteristics subsequent nonfatal myocardial infarction Health Study double-blind placebo-controlled trial alternate-day aspirin mg US male physicians METHODS RESULTS months follow-up incident cases nonfatal myocardial infarction reports aspirin placebo extreme reduction occurrence first nonfatal infarction attributable significant differences size location electrocardiographic features postinfarction ventricular ejection fraction aspirin placebo groups undergoing angiography differences distribution number coronary vessels CONCLUSIONS data chronic platelet inhibition alternate-day aspirin therapy risk first myocardial infarction significant effect clinical characteristics events finding direct effect aspirin aspirin-induced shift infarction severity Regardless mechanism clinical observations treatment decisions acute infarction patients history aspirin use